The Europe nuclear imaging systems market size is expected to reach US$ 1,524.67 million by 2031 from US$ 1,211.89 million in 2024. The market is estimated to record a CAGR of 3.4% from 2025 to 2031.
Executive Summary and Europe Nuclear Imaging Systems Market Analysis:
Europe’s nuclear imaging market is highly developed, driven by clinical innovation, upgrades in infrastructure, and a growing emphasis on precision diagnostics. Hybrid imaging systems are increasingly used, especially in oncology and neurology, where early detection can make a big difference. Both public hospitals and private providers are investing in these technologies to improve workflow and patient care. Germany remains the leader, owing to its strong industry base, active research centers, and widespread clinical adoption. France, Italy, and Spain are steadily expanding their nuclear medicine capabilities, while many Eastern European countries are still modernizing their imaging networks. Harmonized regulations and cross-border research programs help speed up the adoption of new systems. As digital health tools become more closely linked with imaging, nuclear imaging is increasingly central to personalized medicine and value-based care across Europe.
Europe Nuclear Imaging Systems Market Strategic Insights
Key segments that contributed to the derivation of the nuclear imaging systems market analysis are product type, application, and end user.
- By product type, the nuclear imaging systems market is segmented into SPECT systems, PET systems and hybrid systems. The PET systems segment dominated the market in 2024.
- By application, the nuclear imaging systems market is segmented into oncology, cardiology, neurology, endocrinology and others. The oncology segment dominated the market in 2024.
- By end user, the market is segmented into hospitals, specialty clinics, diagnostics imaging centers, academic & research Institutes and others. The hospitals segment held the largest share of the market in 2024.
Europe Nuclear Imaging Systems Market Outlook
Europe’s nuclear imaging market is evolving as hospitals and diagnostic centers bring advanced systems into everyday care. PET/CT and SPECT/CT scanners are increasingly used to support decisions in oncology and cardiology, though adoption levels vary across countries. One important factor is the growing use of AI-based image analysis, which helps radiologists improve accuracy and cut reporting times. Germany is at the forefront, with several institutions testing machine learning tools to make workflows more efficient. Support from the European Union is also encouraging collaboration between manufacturers, researchers, and clinicians, helping to speed up the development of new radiopharmaceuticals and imaging protocols. As health systems focus on efficiency and precision, nuclear imaging is gradually becoming central to outpatient diagnostics, clinical trials, and personalized treatment planning.
Europe Nuclear Imaging Systems Market Country Insights
Based on country, the Europe nuclear imaging systems market is further segmented into Germany, Italy, France, the U.K., Spain, Belgium, the Netherlands, Luxembourg, Norway, Finland, Denmark, Sweden, Austria, Switzerland, Russia, Romania, Greece, the Czech Republic, Portugal, Ukraine, Poland, Slovakia and Bulgaria. Germany held the largest share in 2024.
Germany boasts Europe's largest nuclear imaging market, given its strong clinical experience and manufacturing capabilities. Hospitals and research facilities have PET/MRI and SPECT/CT systems, which facilitate complex diagnostics with an emphasis on oncology and neurology. Manufacturers also partner with academic organizations to develop advanced detectors and radiopharmaceuticals, enhance diagnostic accuracy and expand use across imaging specialties. AI-assisted platforms are increasingly being integrated into hospital networks to improve workflow and provide assessments quickly. In addition, regulatory organizations facilitate and expedite the approval processes to promote the use of new devices. The focus on high-quality, data-driven, patient care creates a predictable and stable infrastructure of imaging services. There are also education and training programs established to train a qualified workforce of nuclear imaging professionals to help manage the advanced systems. Together with the size of their facilities, the available technologies, and regulatory support, Germany remains the leader in nuclear imaging in Europe.
Europe Nuclear Imaging Systems Market Report Highlights
| Report Attribute | Details |
| Market size in 2024 | US$ 1,211.89 Million |
| Market Size by 2031 | US$ 1,524.67 Million |
| CAGR (2025 - 2031) | 3.4% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Product Type
|
|
Regions and Countries Covered
|
|
| Europe | Germany, Italy, France, U.K., Spain, Belgium, Netherlands, Luxembourg, Norway, Finland, Denmark, Sweden, Switzerland, Austria, Greece, Portugal, Russia, Poland, Romania, Czech Republic, Ukraine, Slovakia, Bulgaria |
| Market leaders and key company profiles |
|
Europe Nuclear Imaging Systems Market Company Profiles
GE HealthCare, Siemens Healthineers AG, Canon Inc., Koninklijke Philips N.V., SHIMADZU CORPORATION, United Imaging Healthcare Co., Ltd., Neusoft Medical Systems Co., Ltd., Mediso Ltd., Positron Corporation, and MiE GmbH are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
Europe Nuclear Imaging Systems Market Research Methodology:
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
- Company websites, annual reports, financial statements, broker analyses, and investor presentations
- Industry trade journals and other relevant publications
- Government documents, statistical databases, and market reports
- News articles, press releases, and webcasts specific to companies operating in the market
Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
Primary Research
Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
- Refine findings from secondary research
- Enhance the expertise and market understanding of the analysis team
- Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
- Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
- External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Europe Nuclear Imaging Systems Market Country and Regional Insights
Europe Nuclear Imaging Systems Key Sources Referred:
- The World Bank
- World Health Organization (WHO)
- Center for Disease Control and Prevention (CDC)
- Society of Nuclear Medicine and Molecular Imaging (SNMMI)
- European Association of Nuclear Medicine (EANM)
- American College of Nuclear Medicine (ACNM)
- American Society of Nuclear Cardiology (ASNC)
- Global Cancer Observatory
- Company website
- Company annual reports
- Company investor presentations
